Printing giants Hewlett-Packard (“HP”) brought a claim of infringement against French electronics wholesaler LAMA France (“LAMA”) before the Paris Local Division of the UPC at the end of last year, from which they came out (partially) victorious.
READ MORE
On 1st May 2025, Phase 1 of the EUIPO’s design reform came into effect. Many of the changes brought about by this reform are motivated by a desire to align EU design law with the world around us, which is increasingly manifesting in digital forms.
READ MORE
Huawei brought an action in the Munich local division against Netgear for infringement of EP3611989 in relation to various of its WiFi access point products. Huawei had declared EP’989 to be essential to the IEEE 802.11ax (“WiFi 6”) standard and so was obliged to offer a licence on Fair, Reasonable and Non-Discriminatory (FRAND) terms. However, no licence could be agreed.
READ MORE
Panasonic Holdings Corporation (Panasonic) brought an infringement action against Guangdong OPPO Mobile Telecommunications Corp Ltd and OROPE Germany GmBH (OPPO), accusing OPPO of infringing Panasonic’s patent EP 2 568 724 in their 4G-capable products including smartphones and smartwatches. Emily Dekker, Trainee Patent Attorney discusses this matter in more detail.
READ MORE
Following last week’s historic third consecutive Ferrari outright win at the 24 hours of Le Mans, Dehns Technology, Software and Engineering Associate, Thomas Jeal reflects on another exciting event from this year’s race week: Toyota’s unveiling of their hydrogen combustion engine Hypercar Prototype, the GR LH2 Racing Concept.
READ MORE
With the Supreme Court set to hear the appeal in Emotional Perception AI’s patent application next week, the UK patent profession eagerly awaits the outcome of the appeal.
READ MORE
The EPO Enlarged Board of Appeal has now issued their decision on G2/21, a case which was intended to decide whether evidence submitted after the filing date could be used to support inventive step.
In honour of International Women’s Day 2023, and to acknowledge the achievements of the inspiring women in our network, Dehns has interviewed Hedwig van Driel, Senior Patent Attorney at TomTom International B.V. to highlight her experiences of working in a STEM profession.
Intellectual Property infringement and director’s liability: Lauren Palmer, Legal Assistant at Dehns provides a case analysis of Tangle v One for Fun
In episode two of our special “Women in STEM” podcast series, we interview Rebecca Gardner (Partner) and Rosie Lawrence (Technical Assistant). Rebecca and Rosie work in the Dehns Biotech team and are based in our Brighton office. With Rebecca starting her career in the mid-90s and Rosie joining the workplace in 2020, this episode delves into their different experiences – during their studies and when entering the workplace – and the effect of increased diversity in STEM.
Implication of EPO decision on prior English court decision: Paul Harris, Head of Litigation at Dehns provides a case analysis of Vodafone Group PLC and ors v IPCom GmbH.
What better time to acknowledge the achievements of the women in our firm than the International day of Women and Girls in Science. In celebration of this day, our Senior Partner, Elizabeth Jones, discusses topics ranging from becoming a patent attorney to the importance of normalising the presence of women in STEM (Science, Technology, Engineering and Mathematics) fields.
In honour of International day of Women and Girls in Science, Dehns has interviewed a series of inspiring role models in our network.
Anne Ulvestad, CEO of Arctic Pharma AS, kindly opened up about her experiences in this industry, from her motivation for pursuing a career in STEM to her experience of barriers to entry.
Can adding the company name to a mark avoid infringement?: Lauren Palmer, Legal Assistant at Dehns provides a case analysis of Combe International v Dr Wolff
Arrow declaration misses its target: Paul Harris, Head of Litigation at Dehns, considers the extent to which the Patents Court will go in order to provide a “spin-off value” for one party, in the courts of another jurisdiction.
A balance must be struck between the competing interests of generic and innovator companies to ensure the healthcare system works at its best. At the moment, that longstanding balance has been disrupted by the Federal Circuit and the ripples are still being felt in the generics industry, even if the court has tried to take some of the sting out of its earlier actions.
Subscribe here for updates on IP news, events and webinars.
|